CYH:NYE-Community Health Systems Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 5.7

Change

0.00 (0.00)%

Market Cap

USD 0.63B

Volume

2.94M

Analyst Target

USD 4.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Community Health Systems Inc operates general acute care hospitals in communities across the country. It provide healthcare services through the hospitals in non-urban and selected urban markets throughout the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 105.82B
UHS Universal Health Services Inc

N/A

USD 15.62B
THC Tenet Healthcare Corporation

N/A

USD 15.10B
DVA DaVita HealthCare Partners Inc

N/A

USD 11.58B
EHC Encompass Health Corp

N/A

USD 9.63B
CHE Chemed Corp

N/A

USD 9.04B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 1.83B
AMN AMN Healthcare Services Inc

N/A

USD 1.40B

ETFs Containing CYH

CJNK 0.00 % 0.30 %

N/A

N/A
ETP:CA First Trust Global Risk M.. 0.00 % 0.98 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 82.11% 91% A- 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.11% 91% A- 99% N/A
Trailing 12 Months  
Capital Gain 81.53% 86% B+ 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.53% 86% B+ 98% N/A
Trailing 5 Years  
Capital Gain 72.73% 78% C+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.73% 78% C+ 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 38.92% 91% A- 92% A
Dividend Return 38.92% 91% A- 92% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 120.82% 14% F 6% D-
Risk Adjusted Return 32.21% 55% F 51% F
Market Capitalization 0.63B 47% F 53% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 1.47 87% 98%
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio 3.61 74% 65%
Price/Free Cash Flow Ratio 8.24 63% 55%
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital 7.52% 55% 59%
Return on Assets 4.06% 58% 68%
Debt to Equity Ratio -823.71% 89% 98%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector